ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 661747 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 661747; 2) Community: the network communities that were significantly associated with the response to NSC 661747; 3) Molecule: the relationships between components within communities and NSC 661747; 4) MDR: the compounds that were significantly associated with the NSC 661747.

NSC Compound Enrichment Correlation
NSC 328784 1-Piperazinecarboselenoic acid, 4-(2-pyridinyl)-, [1-(2-pyridinyl)ethylidene]hydrazide 0.0385613993886001 0.03245702
NSC 349622 Cytovaricin 0.0385613993886001 0.04387661
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.0385613993886001 0.15473017
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0385613993886001 0.09565249
NSC 44684 Null 0.0385613993886001 -0.10406212
NSC 55236 Null 0.0385613993886001 0.18425542
NSC 608329 Null 0.0385613993886001 0.14148317
NSC 630606 1-Piperidinecarboxylic acid, 3,5-bis(phenylmethylene)- 4-oxo-, 4-methylphenyl ester 0.0385613993886001 0.10111076
NSC 637505 Null 0.0385613993886001 0.086298708
NSC 639514 Cyclopentanone, 2-[(dimethylamino)methyl]-5- [[4-[(propionyloxy)methoxy]phenyl]methylene]-, hydrochloride 0.0385613993886001 0.0066450436
Total:47  Current:31    [First] [Prev] [Next] [Last]